Literature DB >> 2178320

Effects of some non-steroidal anti-inflammatory drug copper complexes on polymorphonuclear leukocyte oxidative metabolism.

M Roch-Arveiller1, V Revelant, D Pham Huy, L Maman, J Fontagne, J R Sorenson, J P Giroud.   

Abstract

Interaction between anti-inflammatory drugs and reactive oxygen metabolites must be considered in the course of pharmacological studies intended to develop new compounds. Effects of indomethacin, aspirin, and 3,5-diisopropylsalicylic acid (3,5-DIPS) and their copper complexes on PMNL oxidative metabolism and the evolution of an acute inflammatory reaction were studied in the rat. Experiments were performed in vitro by assessment of superoxide generation and reduction of chemiluminescence by PMNLs incubated or not (control) in medium containing various concentrations of these compounds. A dose-related decrease of these parameters was observed, however, copper complexes were found to be more effective than their parent drugs or Cu gluconate. Copper complexes were also more effective anti-inflammatory agents than their parent ligands or Cu gluconate when the volume of exudate and number of exudate PMNLs were assessed after induction of pleurisy in rats by injection of isologous serum. It is concluded that modulation of the PMNL oxidative burst by copper complexes offers an accounting for the anti-inflammatory activity of these compounds.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2178320     DOI: 10.1007/BF02003223

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  30 in total

Review 1.  Pharmacology of free radical scavenging in inflammation.

Authors:  E Arrigoni-Martelli
Journal:  Int J Tissue React       Date:  1985

Review 2.  Copper complexes offer a physiological approach to treatment of chronic diseases.

Authors:  J R Sorenson
Journal:  Prog Med Chem       Date:  1989

3.  [Repeated sampling of rat polymorphonuclear leucocytes from the pleural cavity. Application for the study of leucocyte chemotaxis (author's transl)].

Authors:  J P Giroud; M Roch-Arveiller; O Muntaner
Journal:  Nouv Rev Fr Hematol       Date:  1978

4.  The effect of inhibition of both diacylglycerol metabolism and phospholipase A2 activity on superoxide generation by human neutrophils.

Authors:  R E Muid; B Twomey; M M Dale
Journal:  FEBS Lett       Date:  1988-07-04       Impact factor: 4.124

5.  Copper complexes: a physiologic approach to treatment of chronic diseases.

Authors:  J R Sorenson
Journal:  Compr Ther       Date:  1985-04

6.  The mononuclear response to intrapleural injection in the rat.

Authors:  J V Hurley; G B Ryan; A Friedman
Journal:  J Pathol Bacteriol       Date:  1966-04

7.  Chemotactic factor-induced generation of superoxide radicals by human neutrophils: effect of metabolic inhibitors and antiinflammatory drugs.

Authors:  L Simchowitz; J Mehta; I Spilberg
Journal:  Arthritis Rheum       Date:  1979-07

8.  Copper catalyzed oxidation of ascorbate (vitamin C). Inhibitory effect of catalase, superoxide dismutase, serum proteins (ceruloplasmin, albumin, apotransferrin) and amino acids.

Authors:  R A Løvstad
Journal:  Int J Biochem       Date:  1987

9.  The suppression of granulocyte functions by lipophilic antioxidants.

Authors:  W J Baader; A Hatzelmann; V Ullrich
Journal:  Biochem Pharmacol       Date:  1988-03-15       Impact factor: 5.858

10.  Effects of various drugs on superoxide generation, arachidonic acid release and phospholipase A2 in polymorphonuclear leukocytes.

Authors:  K Taniguchi; M Urakami; K Takanaka
Journal:  Jpn J Pharmacol       Date:  1988-03
View more
  4 in total

1.  Copper-indomethacinate associated with zwitterionic phospholipids prevents enteropathy in rats: effect on inducible NO synthase.

Authors:  V Bertrand; F Guessous; A L Le Roy; B Viossat; H Fessi; A El Abbouyi; J P Giroud; M Roch-Arveiller
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

2.  Agents capable of eliminating reactive oxygen species. Catalase, WR-2721, or Cu(II)2(3,5-DIPS)4 decrease experimental colitis.

Authors:  A Keshavarzian; J Haydek; R Zabihi; M Doria; M D'Astice; J R Sorenson
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

3.  Piroxicam-copper complexes: inhibition of polymorphonuclear leukocyte migration to Pseudomonas aeruginosa chemotactins in vivo and superoxide dismutase-like activity in vitro.

Authors:  D O Sordelli; P A Fontán; C R Amura
Journal:  Agents Actions       Date:  1993-03

4.  Modulation of polymorphonuclear leukocyte responsiveness by copper (II)2 (niflumate)4.

Authors:  M Roch-Arveiller; L Maman; D P Huy; J Fontagne; J P Giroud; J R Sorenson
Journal:  Inflamm Res       Date:  1995-05       Impact factor: 4.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.